Teva Pharms Inc Drug Patent Portfolio

Teva Pharms Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Teva Pharms Inc News

Trends Influencing the Future of the Generic Pharmaceuticals Market - PharmiWeb.com

09 Jan, 2026

Teva Succumbs to Pressure from the Federal Trade Commission | JD Supra

16 Dec, 2025

Forecast and Size of the U.S. Generic Pharmaceuticals Market from 2025 to 2033 | Longevity

15 Dec, 2025

Teva complies with FTC regarding Orange Book entries - BioWorld

12 Dec, 2025

See More